Arcutis Biotherapeutics I... (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

15.29

0.64 (4.37%)

At close: May 02, 2025, 3:02 PM

Arcutis Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	71.33M	88.4M	53.64M	96.45M	65.08M	63.34M	39.39M	3.42M
Short-Term Investments	156.62M	183.46M	355.95M	290.61M	219.36M	37.93M	11.55M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	596K	596K	78K	78K	78K	47K	n/a	n/a
Receivables	73.07M	25.81M	8.46M	n/a	510K	n/a	n/a	n/a
Inventory	14.53M	13.13M	7.51M	1.18M	-510K	n/a	n/a	n/a
Other Current Assets	8.82M	9.53M	4.46M	1.54M	1.54M	1.89M	n/a	n/a
Total Current Assets	335.82M	330.43M	437.41M	402.77M	292.83M	106.47M	51.1M	3.82M
Property-Plant & Equipment	2.99M	3.9M	4.6M	5.3M	5.37M	491K	n/a	n/a
Goodwill & Intangibles	9.48M	6.44M	7.19M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	13.07M	10.93M	11.87M	5.38M	5.44M	538K	n/a	n/a
Total Assets	348.89M	341.37M	449.27M	408.15M	298.27M	107.01M	51.1M	3.82M
Account Payables	14.22M	11.99M	8.83M	7.35M	7.14M	1.41M	1.8M	537K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	820K	n/a	657K	433K	n/a	178K	n/a	n/a
Other Current Liabilities	65.15M	19.07M	13.67M	15.98M	176K	2.1M	116K	n/a
Total Current Liabilities	81.01M	46.67M	37.81M	33.33M	22.6M	5.24M	2.67M	692K
Long-Term Debt	107.2M	201.8M	197.77M	72.35M	n/a	n/a	n/a	966K
Other Long-Term Liabilities	570K	849K	n/a	25K	82K	166.68M	72.41M	7.15M
Total Long-Term Liabilities	110.33M	206.03M	201.89M	77.15M	5.05M	166.8M	72.41M	8.12M
Total Liabilities	191.35M	252.7M	239.69M	110.47M	27.65M	172.04M	75.08M	8.81M
Total Debt	110.58M	205.92M	202.54M	77.56M	4.96M	307K	n/a	966K
Common Stock	12K	9K	6K	5K	4K	n/a	n/a	n/a
Retained Earnings	-1.12B	-981.9M	-719.76M	-408.31M	-201.95M	-66.27M	-24.28M	-5.02M
Comprehensive Income	-7K	4K	-1.09M	-255K	-2K	-1K	n/a	n/a
Shareholders Equity	157.54M	88.67M	209.58M	297.68M	270.62M	-65.03M	-23.99M	-4.99M
Total Investments	156.62M	183.46M	355.95M	290.61M	219.36M	37.93M	11.55M	n/a